Cell-mediated immunity, particularly CD8+ T cell-mediated immunity, has been implicated in controlling HIV replication in humans and has been shown to be capable of inhibiting viral replication in SIV-infected macaques [15], [16], suggesting that vaccines targeting cellular immunity may be beneficial for controlling HIV infection. This evidence concerns the gene CD8A and HIV infectious disease.